Company news

Regentis Biomaterials Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal

October 12, 2026

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

September 11, 2026

Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology

July 20, 2026

Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

July 16, 2026

Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch

July 15, 2026

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

June 17, 2026

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

June 8, 2026

Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones

June 1, 2026

Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant

May 29, 2026

Amendment to Annual Report by Foreign Issuer (Form 20-F/A)

February 27, 2026

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

December 5, 2025

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

December 3, 2025

Decks